| Literature DB >> 27925197 |
Safieh Ebrahimi1, Sara Rezaei1, Parvaneh Seiri1, Mikhail Ryzhikov2, Seyed Isaac Hashemy3, Seyed Mahdi Hassanian1,4,5.
Abstract
The coagulation protease Factor Xa (FXa) triggers a variety of signaling pathways through activation of protease-activated receptors (PARs) and non-PAR receptors. FXa-mediated signaling is strongly implicated in the pathogenesis of several inflammatory diseases including fibrosis, cardiovascular diseases, and cancer. Thus, targeting of FXa can have great clinical significance in terms of the treatment of these disorders. This review summarizes the current knowledge about the mechanism of FXa signaling in cellular and animal systems under (patho) physiological conditions for a better understanding and hence a better management of FXa-induced disorders. J. Cell. Physiol. 232: 1966-1970, 2017.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27925197 DOI: 10.1002/jcp.25714
Source DB: PubMed Journal: J Cell Physiol ISSN: 0021-9541 Impact factor: 6.384